Tci Gene (ROCO:6879) Receivables Turnover : 2.19 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Tci Gene's Revenue for the six months ended in Dec. 2023 was NT$184.0 Mil. Tci Gene's average Accounts Receivable for the six months ended in Dec. 2023 was NT$84.1 Mil. Hence, Tci Gene's Receivables Turnover for the six months ended in Dec. 2023 was 2.19.

Tci Gene Receivables Turnover Historical Data

The historical data trend for Tci Gene's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Receivables Turnover Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

5.73

4.97

5.35

4.50

3.83

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Receivables Turnover	Get a 7-Day Free Trial				2.95	1.95	1.67	2.18	2.19

Competitive Comparison of Tci Gene's Receivables Turnover

For the Biotechnology subindustry, Tci Gene's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tci Gene's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Tci Gene's Receivables Turnover falls into.

Tci Gene Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Tci Gene's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	333.855	/ (	(71.634	+	102.59)	/	2 )
=	333.855	/	87.112
=	3.83

Tci Gene's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

	Receivables Turnover (Q: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2023 )	/ (	(Accounts Receivable (Q: Jun. 2023 )	+	Accounts Receivable (Q: Dec. 2023 ))	/	count )
=	183.992	/ (	(65.638	+	102.59)	/	2 )
=	183.992	/	84.114
=	2.19

Tci Gene (ROCO:6879) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Tci Gene Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Tci Gene's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines